GlassScriptPhysician profile
Daniel John Spencer
NPI 1265924724
$6,924.96
in general payments reported to CMS, 2019-2025
21 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $1,059 · 2021: $118 · 2022: $1,201 · 2023: $2,016 · 2024: $1,694 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,027 · Food and Beverage: $1,974 · Education: $39.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,026.54 |
| Food and Beverage | $1,973.63 |
| Education | $39.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,291.14 | 2022-2025 | Portfolio, Bun-Yo-Matic, Grappler |
| Medwest Associates | $1,099.26 | 2023 | |
| Stryker Corporation | $654.31 | 2019-2023 | Citrefix, Phalinx, Augment Injectable |
| Pylant Medical | $580.77 | 2020 | |
| Integra Lifesciences Corporation | $508.06 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $469.99 | 2019-2020 | |
| Arthrex, INC. | $462.48 | 2023 | |
| Organogenesis INC. | $377.58 | 2022-2025 | Affinity, Cygnus Dual, Puraply |
| Kerecis Limited | $254.07 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $183.28 | 2022-2023 | Krystexxa |
| Medline Industries LP | $181.03 | 2020-2022 | |
| Smith+Nephew, INC. | $149.27 | 2022-2024 | Pico, Renasys Touch |
| Depuy Synthes Sales INC. | $125.02 | 2020-2022 | |
| Treace Medical Concepts, INC. | $120.78 | 2023 | |
| Convatec INC. | $117.04 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $105.23 | 2022-2023 | Diamondback Coronary |
| Acera Surgical, INC. | $69.27 | 2022 | |
| Abbvie INC. | $65.18 | 2025 | |
| Extremity Medical | $51.92 | 2021 | |
| Linvatec Corporation | $38.70 | 2020 | |
| Bioventus LLC | $20.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.